Vascular Dementia: Clinical Trials

4 trials for Vascular Dementia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 enrolling by invitation. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Enrolling by invitation 1

Follow Vascular Dementia: new trials by email Literature Review of Vascular Dementia trials Research Report on Vascular Dementia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imaging of Brain Amyloid Plaques in the Aging Population
Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies
Phase 4Enrolling by invitationMayo Clinic80002008-04-012026-06-23
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
Cilostazol, Aspirin - Vascular Dementia, Stroke
Phase 4CompletedPeking University First Hospital2002008-03-012015-05-06
A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
Cerebrolysin, 0.9% Saline Solution - Vascular Dementia
Phase 4CompletedEver Neuro Pharma GmbH2422006-10-012024-02-21
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
donepezil hydrochloride (Aricept) - Vascular Dementia
Phase 4CompletedEisai Inc.362005-09-012012-05-04

Narrower conditions

Dementia, Vascular (4)  ·  Alzheimer Disease (1)  ·  Dementia (1)  ·  Frontotemporal Dementia (1)  ·  Lewy Body Disease (1)  ·  Stroke (1)

Broader conditions

Arterial Occlusive Diseases (4)  ·  Arteriosclerosis (4)  ·  Brain Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Cerebrovascular Disorders (4)  ·  Intracranial Arterial Diseases (4)  ·  Intracranial Arteriosclerosis (4)  ·  Leukoencephalopathies (4)  ·  Mental Disorders (4)  ·  Nervous System Diseases (4)  ·  Neurocognitive Disorders (4)  ·  Vascular Diseases (4)  ·  Dementia (3)  ·  Basal Ganglia Diseases (1)

Interventions

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  Aspirin (1)  ·  Cilostazol (1)  ·  Donepezil (1)  ·  Saline Solution (1)  ·  cerebrolysin (1)  ·  tau Proteins (1)

Sponsors

Eisai Inc. (1)  ·  Ever Neuro Pharma GmbH (1)  ·  Mayo Clinic (1)  ·  Peking University First Hospital (1)

Countries

China (1)  ·  Philippines (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Huang Yining, MD PhD (1)  ·  Jacqueline Dominguez (1)  ·  Philipp Novak, PhD (1)  ·  Val Lowe, M.D. (1)

Results publications

PMID 20656516, PMID 35833913

NIH funding

R01AG011378 (1), U01AG006786 (1)